Abstract:MicroRNAs (miRNAs) have shown to play a pivotal role in the pathogenesis and maintenance of liver fibrosis by altering expression of their downstream target genes. However, their role in radiation-induced liver fibrosis has not been assessed in detail. Our objective was to evaluate the functional implication of miR-146a-5p in radiation-induced liver fibrosis and the involved downstream target gene(s). The human hepatic stellate cell line LX2 was transfected with miR-146a-5p mimics or inhibitors, and then stimulated with irradiation and TGF-β1. Expression of α-SMA, collagen I was evaluated by quantitative real-time PCR and western blotting. Mouse liver was irradiated to 30 Gy delivered in 5 fractions and was sacrificed 6 weeks after the last fractionated irradiation. miR-146a-5p agomir was delivered to each mouse via the tail vein. Histopathological evaluation and biochemical analysis was performed. Expression of α-SMA and collagen 1 were upregulated in response to irradiation and/or TGF-β1 treatment and miR-146a-5p levels were altered in LX2 cells. Restoration of miR-146a-5p expression suppressed expression of α-SMA and collagen 1 in irradiated and TGF-β1-treated LX2 cells. Subsequent mechanism experiments revealed that miR-146a-5p overexpression inhibited PTPRA expression by binding to its 3'-untranslated region and reduced SRC activation. In addition, enhancement of PTPRA partially reversed the suppressive effect of miR-146a-5p on α-SMA and collagen 1 expression in LX2 cells. In vivo data showed that liver irradiation using a fractionated protocol could induce changes characterized by fibrosis accompanied with a prominent miR-146a-5p decrease. Furthermore, systemic injection of miR-146a-5p agomir increased its level and reduced the amount of α-SMA, collagen 1 and PTPRA in the livers of irradiation-treated mice. The current study demonstrates that miR-146a-5p through PTPRA-SRC signaling and by reducing fibrotic molecules expression may mitigate hepatic fibrosis progression as a consequence of radiation, thus highlighting miR-146a-5p as a potential therapeutic target in radiation-induced liver fibrosis.

MicroRNA-146a-5p Attenuates Fibrosis-related Molecules in Irradiated and TGF-beta1-Treated Human Hepatic Stellate Cells by Regulating PTPRA-SRC Signaling

MicroRNA-146a-5p Represses PTPRA to Mitigate Irradiation-Induced Liver Fibrosis

miR-146a-5p Alleviates Radiation-Induced Liver Fibrosis by Regulating PTPRA-SRC Signaling in Mice.

MicroRNA-146b Regulates Hepatic Stellate Cell Activation Via Targeting of KLF4.

MicroRNA-146a-5p attenuates irradiation-induced and LPS-induced hepatic stellate cell activation and hepatocyte apoptosis through inhibition of TLR4 pathway

Mir-301A-3p Promotes Hepatic Stellate Cells Activation and Liver Fibrogenesis Via Regulating PTEN/PDGFR-β.

MicroRNA-101 Suppresses Liver Fibrosis by Downregulating PI3K/Akt/mTOR Signaling Pathway

MiR-542-3p controls hepatic stellate cell activation and fibrosis via targeting BMP-7.

Upregulation of Mirna-1228-3p Alleviates TGF-β-induced Fibrosis in Renal Tubular Epithelial Cells.

MicroRNA-195-3p promotes hepatic stellate cell activation and liver fibrosis by suppressing PTEN expression

miR-140-5p attenuates hepatic fibrosis by directly targeting TGFβR1

Mir-345–5P Curbs Hepatic Stellate Cell Activation and Liver Fibrosis Progression by Suppressing Hypoxia-Inducible Factor-1Alpha Expression

MicroRNA-942 mediates hepatic stellate cell activation by regulating BAMBI expression in human liver fibrosis

MicroRNA-146a-5p Negatively Regulates Pro-Inflammatory Cytokine Secretion and Cell Activation in Lipopolysaccharide Stimulated Human Hepatic Stellate Cells through Inhibition of Toll-Like Receptor 4 Signaling Pathways

MicroRNA-212 activates hepatic stellate cells and promotes liver fibrosis via targeting SMAD7.

MicroRNA-155 inhibits the pro-fibrogenic activities of TGF-β 1 in human lung fibroblasts

Targeting Transforming Growth Factor Βrii Expression Inhibits the Activation of Hepatic Stellate Cells and Reduces Collagen Synthesis

Mir-185 Inhibits Fibrogenic Activation of Hepatic Stellate Cells and Prevents Liver Fibrosis.

MicroRNA-30 Protects Against Carbon Tetrachloride-induced Liver Fibrosis by Attenuating Transforming Growth Factor Beta Signaling in Hepatic Stellate Cells

Mir-488-5p Mitigates Hepatic Stellate Cell Activation and Hepatic Fibrosis Via Suppressing TET3 Expression

Proteomic Profiling of Human Hepatic Stellate Cell Line LX2 Responses to Irradiation and TGF-β1